• Text size
  • A
  • A
  • A
**We are still available during the COVID-19 outbreak but we may take a little longer to get back to you**

Prescribing of Methotrexate

A lady got in touch with our Engagement Team to discuss her queries about prescribing of Methotrexate.

Our Engagment Officer rang the Sunderland Clinical Commissioning Group's Medice Optimisation Team and found out the following information for this lady:

Methotrexate is one of the medications which can have a shared care agreement between a GP and the Consultant at a hospital. This allows for the patients easy access to blood tests etc and for the GP to prescribe medications to the patient and the Consultant to offer review appointments to the patient.

As a medicine like Methotrexate needs a lot of monitoring, for both side to sign off this clinical agreement, they both have to be sure that patient safety is at the forefront.  We were re-assured that this is nothing to do with funding for the medication. There are certain criteria that all have to be in place before both sides will sign the agreement.

You can find more information about the Shared Care agreements here and there is a dedicated document for Methotrexate.

Our Engagement Officer asked why the hospital prescriptions can't be sent to community pharmacies as this would allow medications to be delivered along-side other items:

The hospital does not yet have the IT infrastructure in place to do this, although there is a national piece of work happening at the moment to hopefully change this!

The lady was asked to get in touch with Rheumatology and ask if her medicine can be delivered during the pandemic, they may be able to do this but the consultant would need to approve this.

Published: 03/02/2021


Receive our newsletter